These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11964918)

  • 1. Update on community-acquired pneumonia: impact of antibiotic resistance on clinical outcomes.
    Metlay JP
    Curr Opin Infect Dis; 2002 Apr; 15(2):163-7. PubMed ID: 11964918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance.
    Metlay JP; Singer DE
    Clin Microbiol Infect; 2002; 8 Suppl 2():1-11. PubMed ID: 12427205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the relevance of antimicrobial resistance on the outcome of community-acquired pneumonia caused by Streptococcus pneumoniae? (should macrolide monotherapy be used for mild pneumonia?).
    Low DE
    Infect Dis Clin North Am; 2013 Mar; 27(1):87-97. PubMed ID: 23398867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
    Rothermel CD
    Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program.
    Gordon KA; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2003 Aug; 46(4):285-9. PubMed ID: 12944021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia.
    Aspa J; Rajas O; de Castro FR
    Expert Opin Pharmacother; 2008 Feb; 9(2):229-41. PubMed ID: 18201146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of antibiotic resistance in respiratory tract infections.
    Klugman KP
    Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S6-10. PubMed ID: 17307654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotic therapy for community acquired Streptococcus pneumoniae pneumonia: clinical relevance of antibiotic resistance].
    Bédos JP; Bruneel F
    Med Mal Infect; 2006; 36(11-12):667-79. PubMed ID: 16842956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the burden of pneumococcal disease in adults.
    Blasi F; Mantero M; Santus P; Tarsia P
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():7-14. PubMed ID: 22882668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic non-susceptibility among Streptococcus pneumoniae and Haemophilus influenzae isolates identified in African cohorts: a meta-analysis of three decades of published studies.
    Ginsburg AS; Tinkham L; Riley K; Kay NA; Klugman KP; Gill CJ
    Int J Antimicrob Agents; 2013 Dec; 42(6):482-91. PubMed ID: 24139883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antimicrobial resistance on health outcomes in the out-patient treatment of adult community-acquired pneumonia: a probability model.
    Singer ME; Harding I; Jacobs MR; Jaffe DH
    J Antimicrob Chemother; 2003 May; 51(5):1269-82. PubMed ID: 12697646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vivo-in vitro paradox in pneumococcal respiratory tract infections.
    Bishai W
    J Antimicrob Chemother; 2002 Mar; 49(3):433-6. PubMed ID: 11864942
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii.
    Ho PL; Cheng VC; Chu CM
    Chest; 2009 Oct; 136(4):1119-1127. PubMed ID: 19809053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA; Ehrhardt AF; Jones RN
    Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamics.
    Opatowski L; Mandel J; Varon E; Boëlle PY; Temime L; Guillemot D
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2330-7. PubMed ID: 20231396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptococcus pneumoniae: epidemiology and patterns of resistance.
    Jacobs MR
    Am J Med; 2004 Aug; 117 Suppl 3A():3S-15S. PubMed ID: 15360092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.